Related Experiment Video

Updated: Mar 14, 2026

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.8K

Viruses as nanomedicine for cancer

Narayanasamy Badrinath1, Jeong Heo2, So Young Yoo3

  • 1BIO-IT Foundry Technology Institute.

International Journal of Nanomedicine
|October 6, 2016
PubMed

Insights

Oncolytic virotherapy uses oncolytic viruses (OVs) to target and destroy cancer cells, stimulating an immune response. Vaccinia virus shows promise as an anticancer nanomedicine in clinical trials.

Area of Science:

  • Oncolytic virotherapy
  • Nanomedicine
  • Cancer therapy

Background:

  • Oncolytic viruses (OVs) are emerging as a novel cancer treatment.
  • OVs selectively infect and lyse cancer cells, potentially requiring genetic modification for enhanced efficacy.
  • OVs can also stimulate the host immune system against tumors.

Purpose of the Study:

  • To review the mechanisms of oncolytic virotherapy.
  • To discuss the latest research on vaccinia virus-based virotherapy.
  • To evaluate the status of vaccinia virus as an anticancer nanomedicine in clinical trials.

Main Methods:

  • Review of basic mechanisms of OV action (entry, survival, lysis, immune activation).
  • Analysis of current research in vaccinia virus-based oncolytic virotherapy.
  • Examination of clinical trial data for vaccinia virus as a nanomedicine.

Main Results:

  • OVs demonstrate dual action: direct tumor cell killing and induction of anti-tumor immunity.
  • Vaccinia virus possesses favorable properties for oncolytic virotherapy.
  • Vaccinia virus-based therapies are progressing towards and are in clinical trials.

Conclusions:

  • Oncolytic virotherapy, particularly using vaccinia virus, represents a promising nanomedicine approach for cancer treatment.
  • Further clinical investigation is warranted to establish the full therapeutic potential of OVs.
  • The combination of viral lysis and immune activation offers a potent strategy against cancer.
Keywords:
cancer therapyoncolytic virusesvaccinia virusvirotherapy

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging08:04

Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging

Published on: June 21, 2011

18.9K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K